Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for Endometriosis Pain
NCT02079974Withdrawn
- Start
- Jul 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pravastatin in endometriosis. Primary endpoint: Subjective assessment of pain at 3 months. Planned start Jul 2014; status: withdrawn.
02
Drugs
pravastatin
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02079974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079974.